Neurocrine Biosciences Inc (NASDAQ:NBIX)

98.23
Delayed Data
As of Jun 24
 +0.83 / +0.85%
Today’s Change
71.88
Today|||52-Week Range
108.02
+15.33%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Gano Kyle W
Chief Business Development Officer
Sale1/05/202228,266$85.50$2.4M+18.01%
Lloyd-smith Malcolm C
Chief Regulatory Officer
Sale7/27/202116,709$93.80$1.6M+4.40%
Lyons Gary A
Director
Sale4/25/202215,000$92.76$1.4M+4.78%
Sherwin Stephen A
Director
Sale1/24/202215,000$74.43$1.1M+29.50%
Rastetter William H
Director
Sale4/01/202210,728$94.93$1.0M+2.79%
Lippoldt Darin M
Chief Legal Officer
Sale3/22/20228,455$95.05$803.6K+3.62%
Pops Richard F
Director
Sale5/09/20227,500$76.30$572.3K+29.62%
Pops Richard F
Director
Sale5/09/20227,500$76.29$572.2K+29.62%
Lyons Gary A
Director
Sale10/07/20215,000$105.06$525.3K-4.66%
Grigoriadis Dimitri E
Chief Research Officer
Sale10/07/20215,000$104.85$524.3K-4.66%
Page of 6